The registration documents for heparin sodium active pharmaceutical ingredient have been successfully submitted and accepted domestically.

After more than six months of concerted efforts by the Pharmaceutical Administration Department and all members of the Production Quality System, the company has completed all preparatory work for the initial preparation of the domestic registration documents for its sodium heparin active pharmaceutical ingredient. Recently, these documents were formally submitted to the Hubei Provincial Administration for Market Regulation and Food and Drug Administration, and the company has received a notice of acceptance.